Arkolith/Insider Trading/BICX/Form 4

Felix Lourdes

CEO and CFO, DirectorBioCorRx Inc. (BICX) · full profile →Form 4 · filed Jan 31, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2024Grant(A)13K—$0844K
Sep 30, 2024Grant(A)16K—$0830K
Jul 2, 2024Grant(A)500K—$0815K
Apr 24, 2024Grant(A)224K—$0315K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-25-000576) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML